Medication info
Twinon 40/10 mg Tablets

Twinon 40/10 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›167.36mg / 1 tabletTelmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Korea Chorus Co., Ltd.
Appearance
For domestic use: white or whitish rectangular tablets For export: oval double-coated tablets with white and light gray on both sides.
Packaging
30 tablets/box [(10 tablets/Alu-Alu*3)], 30 tablets/bottle
Approval status
Active

MFDS item code 201706874 · Approved 2017.08.29 · Insurance code 647204410

Summary

Main use
Treatment of essential hypertension uncontrolled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this product is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the dose of the individual components (amlodipine or telmisartan) be adjusted before administering this product. However, direct switching to this product may be considered if blood pressure is not controlled with an individual component, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this product 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ◦ Patients with renal impairment: No dose adjustment is required for patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution in Administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
◦ Children: The safety and efficacy of this product have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Korea Chorus Co., Ltd.

Efficacy & effects

Treatment of essential hypertension uncontrolled by monotherapy

  • Essential hypertension
View approved original text

In patients with essential hypertension, when blood pressure is not adequately controlled with amlodipine or telmisartan monotherapy, combining the two medications can effectively lower blood pressure. This treatment helps improve hypertension through vasodilation or controlling blood pressure. Therefore, this medication aids in the control of blood pressure in essential hypertension.

How to take

Adult dose

The recommended dose of this product is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the dose of the individual components (amlodipine or telmisartan) be adjusted before administering this product. However, direct switching to this product may be considered if blood pressure is not controlled with an individual component, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this product 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ◦ Patients with renal impairment: No dose adjustment is required for patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution in Administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

◦ Children: The safety and efficacy of this product have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. It should not be administered to patients with allergies to its active ingredients, liver impairment, severe hypotension, or certain specific heart conditions. Patients with impaired liver function, gastrointestinal disorders, kidney issues, and the elderly should exercise caution when using this medication. Common side effects may include dizziness or swelling, and in rare cases, serious side effects may occur. Women planning to become pregnant or currently pregnant should not take this medication, and it should be discontinued immediately if pregnancy is confirmed. Patients with low blood pressure or impaired kidney function should consult a doctor before taking this medication and should regularly monitor their blood pressure and kidney functions during treatment. This medication may interact when taken with other antihypertensive medications or specific drugs, so it is crucial to inform the healthcare provider about any other medications being taken. Breastfeeding women are advised not to take this medication, and it is not recommended for children or adolescents under 18 years old. In case of overdose, severe hypotension, dizziness, or heart problems may occur; therefore, the dosage should be strictly adhered to, and if any unusual symptoms occur, immediate medical attention should be sought. This medication should be stored out of reach of children, in a dark, airtight container, and should be taken immediately after opening for safety.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 102 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusional state
  • drowsiness
  • headache
  • migraine
  • sensory disturbance
  • sensory loss
  • dysgeusia
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • intestinal air retention
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver disease
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • sweating
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • acute renal failure
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • interstitial lung disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light and should be stored in a light-resistant, sealed container. It is important to maintain a storage temperature between 1 to 30 degrees Celsius. This will help preserve the effectiveness of the medication.

Appearance and packaging

Appearance

For domestic use: white or whitish rectangular tablets For export: oval double-coated tablets with white and light gray on both sides.

Package unit

30 tablets/box [(10 tablets/Alu-Alu*3)], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.